The Global Radiopharmaceuticals Market size was valued at around USD 7.11 billion in 2024 and is projected to reach USD 12.73 billion by 2030. Along with this, the market is estimated to grow at a CAGR of around 10.19% during the forecast period, i.e., 2025-30.     

Radiopharmaceuticals Market Driver:

Increasing Prevalence of Chronic Diseases – There are a large number of patients with cardiovascular diseases globally due to factors, such as changing lifestyles, obesity, an aging population, improved survival rates from heart attacks and strokes, etc. For instance, the British Heart Foundation stated in 2024 that, around 620 million, which makes 1 in 13 people, are living with heart and circulatory diseases across the world.

With that, the adoption of radiopharmaceuticals to perform diagnosis and risk assessment and to monitor the influence of therapies on heart conditions is witnessing growth, propelling the overall Radiopharmaceuticals Market. Also, the prevalence of cancer is increasing across the globe and this is expected to drive the demand for radiopharmaceuticals

Download a free sample copy of the Report: https://www.marknteladvisors.com/query/request-sample/radiopharmaceuticals-market.html

Key Market Reports Highlights

·        Market Dimensions & Projections

·        Pricing Evaluation

·        Recent Strategic Moves by Companies

·        Primary Stakeholders

·        Import/Export Trend Analysis

·        Competitive Landscape Assessment

·        Emerging Opportunities

·        Market Trends and Indicators

*Reports Delivery Format - Market research studies from MarkNtel Advisors are offered in PDF, Excel and PowerPoint formats. Within 24 hours of the payment being successfully received, the report will be sent to your email address.

Browse Full Report including (TOC+ List of Table and Figures): https://www.marknteladvisors.com/research-library/radiopharmaceuticals-market.html

Radiopharmaceuticals Market Segmentation:

The market report categorizes the market based on different segments and geographical analysis.

Study Timeline:

-Base Year: 2024

-Historical Period: 2020 to 2023

-Forecast Period: 2025 to 2030

• By Radioisotope
  • Technetium 99- Market Size & Forecast 2020-2030, USD Million
  • Fluorine 18- Market Size & Forecast 2020-2030, USD Million
  • Iodine 131- Market Size & Forecast 2020-2030, USD Million
  • Gallium 68- Market Size & Forecast 2020-2030, USD Million
  • Iodine 123- Market Size & Forecast 2020-2030, USD Million
  • Others (Yttrium 90, Indium 111, etc.)- Market Size & Forecast 2020-2030, USD Million
• By Indication
  • Oncology- Market Size & Forecast 2020-2030, USD Million
  • Cardiology- Market Size & Forecast 2020-2030, USD Million
  • Gastroenterology- Market Size & Forecast 2020-2030, USD Million
  • Nephrology- Market Size & Forecast 2020-2030, USD Million
  • Others (Neuroendocrinology, Neurology, etc.)- Market Size & Forecast 2020-2030, USD Million
• By Type
  • Diagnostic- Market Size & Forecast 2020-2030, USD Million
  • Therapeutic- Market Size & Forecast 2020-2030, USD Million
• By End User
  • Hospitals- Market Size & Forecast 2020-2030, USD Million
  • Medical Imaging Centers- Market Size & Forecast 2020-2030, USD Million
  • Others (Specialty Clinics, Research Organizations, etc.)- Market Size & Forecast 2020-2030, USD Million
• By Region
  • North America
  • South America
  • Europe
  • The Middle East & Africa
  • Asia-Pacific

Competitive Landscape

With strategic initiatives, such as mergers, collaborations, and acquisitions, the leading market companies, including - Bayer AG, Iso-Tex Diagnostics, Inc., Jubilant Pharmova Limited, Novartis AG, General Electric Company, Lantheus Holdings, Inc., Eli Lilly and Company, Siemens Healthineers AG, Curium Pharma, Cardinal Health, Blue Earth Diagnostics, Inc. (Bracco Group), Acrotech Biopharma, Northstar Medical Technologies LLC, IBA Radiopharma Solutions, Sun Pharmaceutical Industries, Inc.

Have questions? Our consultant is ready to assist: https://www.marknteladvisors.com/query/talk-to-our-consultant/radiopharmaceuticals-market.html

We follow a tried-and-tested research methodology that blends top-down and bottom-up approaches to deliver highly accurate market insights. Every report is powered by data triangulation, ensuring well-rounded and validated findings.

From smart sample selection and reliable data collection to in-depth analysis and precise forecasting, our process is designed to minimize error and maximize impact.

About Us –

MarkNtel Advisors is a leading consulting, data analytics, and market research firm that provides an extensive range of strategic reports on diverse industry verticals. We being a qualitative & quantitative research company, strive to deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, and individuals, among others.

We have our existence across the market for many years and have conducted multi-industry research across 80+ countries, spreading our reach across numerous regions like America, Asia-Pacific, Europe, the Middle East & Africa, etc., and many countries across the regional scale, namely, the US, India, the Netherlands, Saudi Arabia, the UAE, Brazil, and several others.

Contact Us

MarkNtel Advisors

Email: sales@marknteladvisors.com

Website: www.marknteladvisors.com

Latest Press Release - https://www.marknteladvisors.com/press-release